2024 Pharm Exec Top 50 Companies
Jun 14, 2024 · As we noted in last year’s report, Novo Nordisk and Eli Lilly, competing in the lucrative GLP-1 receptor agonist space that, of late, has captivated the US and beyond in weight loss, are knocking loudly on the top-10 door.Both companies, who own the highest market caps, respectively, in pharma, turned in massive growth in our latest Pharma 50.
Pharmaceutical Executive
Master the Science of Success through aspirational coverage for executive-level decisions, leadership, management, strategy and commercialization professionals.
Understanding IDNs and What They Mean to the Pharmaceutical …
Aug 2, 2024 · Integrated Delivery Networks have changed the healthcare landscape over the past decade. Greg Skalicky, president and chief revenue officer at EVERSANA, spoke with Pharmaceutical Executive about the ways that commercialization teams are working with these networks to bring drugs to markets.
FDA Grants 510(k) Clearance to Cresilon’s Traumagel for
Aug 16, 2024 · The FDA has granted 510(k) clearance to Traumagel, Cresilon’s plant-based gel designed for temporary external control of moderate to severe bleeding.
Biopharma Trends in 2024 and Beyond - PharmExec
Jan 17, 2024 · The Inflation Reduction Act (IRA), mergers and acquisitions, obesity-control drugs, and artificial intelligence (AI) dominated the pharma industry’s headlines in 2023.
Cold Chain: Delivering Innovative Specialty Pharmaceutical
Oct 11, 2021 · Expanding global access to innovative specialty products is vital to improve patient outcomes and maximize product success. The distribution of these therapies—from the manufacturer’s facility all the way to the site of care—demands flawless execution, as an unbroken temperature chain is essential to both patient safety and product success.
Pharmaceutical Executive - PharmExec
Master the Science of Success through aspirational coverage for executive-level decisions, leadership, management, strategy and commercialization professionals.
2024Finalists - pharmexec.com
Agency: Avant Healthcare Pharmaceutical Company: UCB Campaign: Make HStory (US HCP Campaign) Agency: ClinicalMind Pharmaceutical Company: TruElastin Laboratories, Inc. Campaign: Pushing the limits of aesthetics Agency: MedTrix Healthcare Pharmaceutical Company: Allergan Medical Institute, An Abbvie Company Campaign: The Virtual Patient Simulator (VPS): A Revolutionary Approach to Aesthetic ...
Amgen's Novel Weight Loss Drug Shows Potential for Longer …
Feb 6, 2024 · Amgen’s novel weight loss drug candidate maridebart cafraglutide (MariTide) showed significant promise in a Phase I trial (NCT04478708), with data suggesting longer lasting and durable reductions in body weight compared with the popular glucagon-like peptide (GLP)-1 agonists currently on the market—Novo Nordisk’s Wegovy (semaglutide) and Eli …
Podcasts - PharmExec
In this episode of the Pharmaceutical Executive podcast, Shubh Goel, head of immuno-oncology, gastrointestinal tumors, US oncology business unit, AstraZeneca, discusses the findings of the NIAGARA trial in bladder cancer and the significance of the five-year overall survival data from the HIMALAYA trial, particularly the long-term efficacy of the …